# FDA Inspection 1217191 - Gregory D. Parkhurst, MD - September 01, 2023

Source: https://www.keypedia.com/records/fda_inspections/gregory-d-parkhurst-md/cc0caf09-2fd6-43e5-85d5-04753b341251
Source feed: FDA_Inspections

> FDA Inspection 1217191 for Gregory D. Parkhurst, MD on September 01, 2023. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1217191
- Company Name: Gregory D. Parkhurst, MD
- Inspection Date: 2023-09-01
- Classification: No Action Indicated (NAI)
- Project Area: Bioresearch Monitoring
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1264352 - 2025-03-13](https://www.keypedia.com/records/fda_inspections/gregory-d-parkhurst-md/8710f272-798e-4eed-a523-7ffc96dae144)
- [FDA Inspection 1264352 - 2025-03-13](https://www.keypedia.com/records/fda_inspections/gregory-d-parkhurst-md/fdee8c12-9103-496b-b45f-a84582bc1594)

Company: https://www.keypedia.com/companies/gregory-d-parkhurst-md/dba83b21-7ca1-45e0-96a3-0cc989db0677

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c